Research Square · Sep 29, 2026
Rising Burden and Future Projections of Tobacco-Associated Ischemic Heart Disease Mortality in the United States: A CDC WONDER and Joinpoint Regression Analysis, 1999–2035
By Hamzah KA, Shahzaib M, Gul S et al.
Abstract Background: Tobacco use is a major modifiable risk factor for ischemic heart disease (IHD) and contributes to atherosclerosis, inflammation, endothelial dysfunction, and thrombosis. Although overall IHD mortality in the United States has declined over recent decades, the temporal patterns and population-level disparities in IHD mortality among individuals with documented tobacco use remain incompletely characterized. Objective: To evaluate temporal trends, demographic and geographic disparities, and future projections of tobacco-associated IHD mortality among U.S. adults aged ≥ 25 years from 1999 through 2024, with projections through 2035. Methods: We conducted a retrospective population-based study using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Multiple Cause-of-Death database. Tobacco-associated IHD deaths were identified among adults aged ≥ 25 years when IHD (ICD-10 codes I20–I25) was listed as the underlying cause of death and tobacco use was documented as a contributing condition. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 U.S. standard population. Temporal trends were evaluated using Joinpoint regression to estimate annual percent changes (APCs) and average annual percent changes (AAPCs). Autoregressive integrated moving average (ARIMA) models were used to project mortality through 2035. Results: A total of 953,967 tobacco-associated IHD deaths were identified between 1999 and 2024. Overall AAMRs increased significantly from 1999 to 2005 (APC, 40.78%; 95% CI, 30.22–52.20) and continued to increase from 2005 to 2020, although at a slower rate (APC, 2.40%; 95% CI, 1.36–3.46). From 2020 to 2024, AAMRs declined nonsignificantly (APC, − 4.07%; 95% CI, − 9.69 to 1.91), while the overall trend remained significantly increasing (AAPC, 9.38%; 95% CI, 7.17–11.65). Mortality was consistently higher among males and older adults and varied substantially across racial/ethnic, regional, and urbanization groups. Black or African American individuals had the greatest overall increase in AAMR (AAPC, 10.13%; 95% CI, 7.89–12.41), while rural and micropolitan populations experienced a particularly high mortality burden. ARIMA projections indicated that the overall AAMR may decline from 11.69 per 100,000 in 2024 to 9.13 per 100,000 by 2035; however, important subgroup disparities are expected to persist, with projected increases among adults aged 65–74 years, Black or African American individuals, and nonmetropolitan populations. Conclusions: Tobacco-associated IHD mortality increased substantially in the United States from 1999 to 2024, despite a nonsignificant decline during 2020–2024. Although overall mortality is projected to decline through 2035, substantial demographic and geographic disparities are expected to persist, with increasing mortality projected in several high-risk populations. Targeted tobacco cessation, equitable cardiovascular prevention, and improved access to preventive and cardiovascular care are needed to reduce the burden of tobacco-associated IHD mortality.